Dr. Michael Garshick

[Dr. Michael Garshick @garshick]

Thanks to all our participants. @Bweber04 @amitvkhera @jctardif_mhi @AllanLKleinMD1 @DrMichaelShapir @NehalMehtaMD

[NYU CVD Prevention @NYUCVDPrevent]

Starting tomorrow! 🫀🔥

Follow #CVinflame2026 + Dr. Rafael Toro (@RafaelEToroM), CardioNerds Conference Scholar, for live updates from the 6th Annual North American #CardioRheum Symposium.

Still need to register? ⤵️
https://t.co/SB3SAaQyeO

@CardioNerds @garshick @Bweber04

[NYU CVD Prevention @NYUCVDPrevent]

🔎Spotlight on Sjögren’s at our #CardioRheumatology CME!

Sjögren’s expert Teja Kapoor, MD will review the comprehensive systemic and cardiovascular manifestations of Sjögren’s.

Sign up here ⤵️
https://t.co/SB3SAaQyeO

[theheartorg | Medscape @theheartorg]

🥊 It’s debate ⏰ time. See top 🫀 cardiology minds go head-to-head on today’s toughest questions at #HeartofCardio 2026 in Miami Beach. 🔗 https://t.co/vUoLVt4RRL

Join dream team: @ba_steinberg | @ChiadiNdumele | @MCoylewright | @AJBloodMD | @manesh_patelMD | @HeartDocSadiya | @garshick

[Circulation Research @CircRes]

Check out the latest review in the Jan 16th issue of @CircRes by @IntmedAbel & colleagues "A Road Map to Understanding #CVD in #Diabetes" at https://t.co/HjMjLaLDGo
@SaumyaDas_Lab @naomihamburg @ChiaraGiannare1 @jdnewmanMDMPH @lab_ej @ddbergMD @garshick

[Ron Blankstein @RonBlankstein]

Excited to share our @JACCJournals #JACCIMG paper led by ⭐️@Bweber04 on AI detection of CAC on chest CT among 2,546 individuals with IMID (SLE/RA/Psoriasis) who did not have hx of ASCVD ~50% had CAC --> most not on statin!
➡️Over 8 yrs, AI CAC provided robust a/w MACE + ACM

[NYU CVD Prevention @NYUCVDPrevent]

How do statins enhance endothelial health & reduce #inflammation?

Dr. Michael Garshick will present important findings from the Cardiometabolic Health Strategically Focused Research Network.

Mon, 11/10, 11:06-11:11 AM
Basic Sci Zone
Moderated Digital Poster 26: VB.MDP.16

[NYU CVD Prevention @NYUCVDPrevent]

Register for the 5th Annual #CardioRheum symposium and get free access to Medscape’s 1 hour mini-symposium: ‘Race Against Inflammation: ASCVD & #CKD Risk Reduction Insights.’ Join in-person or virtually—don’t miss the main event + bonus content!

Sign up: https://t.co/SB3SAaQyeO

[NYU Grossman School of Medicine @nyugrossman]

2/Psoriasis is a skin disease that causes inflammation, and it’s been linked to heart problems. Michael Garshick, MD, director of the Cardio-Rheumatology Program, explores how inflammation in psoriasis may promote plaque buildup in arteries.
📍Sat, 11AM CT | Session 1041

[NYU CVD Prevention @NYUCVDPrevent]

NYU Langone cardiology faculty kick off #ACC25 in style!

Stay tuned for exciting conference updates from @nyugrossman, highlighting the latest in #cardiovascular research and innovation.

[Pablo Corral MD @drpablocorral]

👉Two great manuscripts about inflammation and CVD

🔓Open Access

1️⃣Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases

☝️This review summarizes the main characteristics and findings of completed and upcoming randomized controlled trials directly targeting inflammation in CVDs, and discusses major challenges and future perspectives in the exciting and constantly expanding landscape of cardioimmunology

https://t.co/I0GliSAQdB

2️⃣ Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay

☝️ This review aims to critically evaluate the current understanding of the relationship between immune-mediated inflammatory diseases and dyslipidemia, the underlying mechanisms contributing to atherogenesis, and the impact of various pharmacotherapies on lipid profiles and cardiovascular risk. We also discuss the role of lipid-lowering therapies, particularly statins, in managing residual risk in this high-risk population and explore the potential of emerging therapies with complementary anti-inflammatory and lipid-lowering effects.

https://t.co/lFScUsPuLI

@society_eas
@atvbahajournals

[Dr. Michael Garshick @garshick]

Thanks Joel for highlighting our work!. @NPF @PskinPscientist @DrJoelGelfand @NYUCVDPrevent @Bweber04 @nyulangone

[Issam Motairek, MD @IMotairek]

Important research by our cardio-rheumatology center @CleClinicHVTI

[Michael Wilkinson @MWilkinsonMD]

Much to learn about relationship between Lp(a) & inflammation ?mechanisms ?impact on CVD risk. Pooled baseline data from phase 3 trials ⬆️ Lp(a) more prevalent in RA & psoriatic arthritis than ASCVD
@Lpa_Doc @hsbhatia @PamTaubMD @DrMichaelShapir @garshick @Bweber04 @CBallantyneMD

[Dr. Michael Garshick @garshick]

Honored to work with this group and the AHA helping providers treat recurrent pericarditis! ⁦@Bweber04⁩ ⁦@nyulangone⁩ ⁦@NYUCVDPrevent⁩ ⁦@NYULHCVRC⁩

[Monica Mukherjee MD, MPH @MMukherjeeMD]

Oh, what a night! Thrilled to spend time with my #CardioRheum colleagues at #AHA24, sharing friendship while advancing the scientific intersection of cardiology and rheumatology in beautiful Chicago ✨

[Eugene Yang @DrEugeneYang]

Hanging at #AHA24 with the #Cardiorheumatology team for ⁦@ACCinTouch⁩ #CVPrev ⁦@EugeniaGianos⁩ ⁦@garshick⁩ ⁦@Bweber04⁩ ⁦@RonBlankstein⁩

[Dr. Michael Garshick @garshick]

Happy to apart of this network. ⁦@AbbateAntonio⁩ ⁦@Bweber04⁩ ⁦@nyulangone⁩ ⁦@NYUCVDPrevent⁩ ⁦@NYULHCVRC⁩

[Dr. Michael Garshick @garshick]

@Bweber04

[Dr. Michael Garshick @garshick]

Great collaboration between cardiology, congenital cardiology, and ct surgery. ⁦@nyulangone⁩ ⁦@NYUCVDPrevent⁩ ⁦@NYULHCVRC⁩

[Dr. Michael Garshick @garshick]

Great collaboration between cardiology, congenital cardiology, and ct surgery. ⁦@nyulangone⁩ ⁦@NYUCVDPrevent⁩ ⁦@NYULHCVRC⁩

[Dr. Michael Garshick @garshick]

@Dr_DanMD @CardioNerds @Bweber04 @RichardAFerraro @Gurleen_Kaur96 @BreannaHansen_ @AniaCoats @NYUCVDPrevent